Management of advanced stage uterine sarcomas: A bone of contention

European Journal of Gynaecological Oncology

Volumn 30, Issue 5, 2009, Pages 483-492

  Zagouri, F ^a   Linardou, H ^b   Dimopoulos, A M ^a   Papadimitriou, C A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b METROPOLITAN HOSPITAL   (Greece)

Author keywords

Advance stage; Chemotherapy; Radiation; Surgery; Uterine sarcomas

Indexed keywords

AROMATASE INHIBITOR; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; GESTAGEN; IFOSFAMIDE; MEGESTROL ACETATE; MESNA; PACLITAXEL; TEMOZOLOMIDE; TRABECTEDIN;

ABDOMINAL HYSTERECTOMY; ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG FATALITY; ENDOMETRIUM SARCOMA; GASTROINTESTINAL TOXICITY; GRANULOCYTOPENIA; HISTOPATHOLOGY; HUMAN; LEIOMYOSARCOMA; LEUKOCYTE DISORDER; LUNG METASTASIS; MALIGNANT MIXED MULLERIAN TUMOR; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; PROGNOSIS; RECURRENT CANCER; REVIEW; SALPINGOOOPHORECTOMY; SEPSIS; STROKE; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERUS SARCOMA; VOMITING;

CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SARCOMA; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 70350072339     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (134)

1. Salazar O.M., Bonfiglio T.A., Patten S.F., Keller B.E., Feldstein M., Dunne M.E. et al.: "Uterine sarcomas: natural history, treatment and prognosis". Cancer, 1978, 42, 1152.
2. Nordal R.R., Thoresen S.O.: "Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality". Eur. J. Cancer, 1997, 33, 907.
3. Harlow B.L., Weiss N.S., Lofton S.: "The epidemiology of sarcomas of the uterus". J. Natl. Cancer Inst., 1986, 76, 399.
4. Papadimitriou C.A., Zorzou M.P., Markaki S., Rodolakis A., Voulgaris Z., Bozas G. et al.: "Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience". Eur. J. Gynaecol. Oncol., 2007, 28, 109.
5. Jonson A.L., Bliss R.L., Truskinovsky A., Judson P., Argenta P., Carson L. et al.: "Clinical features and outcomes of uterine and ovarian carcinosarcoma". Gynecol. Oncol., 2006, 100, 561.
6. Berchuck A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., Lewis J.L. Jr.: "Treatment of uterine leiomyosarcoma". Obstet. Gynecol., 1988, 71, 845.
7. Kempson R.L., Bari W.: "Uterine sarcomas. Classification, diagnosis, and prognosis". Hum. Pathol., 1970, 1, 331.
8. I. Damjanov and Fang Fan, Eds. Cancer Grading Manual, New York, Springer, 2007, 64.
9. Zaloudek C., Hendrickson M.R.: "Mesenchymal tumors of the uterus". In: Kurman R.J. (ed.). Blaustein's Pathology of the Female Genital Tract. New York, Springer-Verlag, 2002, 561.
10. Ramondetta L., Bodurka D., Deavers M., Jhingran A.: "Uterine sarcomas". In: Eifel P.J., Gershenson D.M., Kavanagh J.J., Silva E.G. (eds.). M.D. Anderson Cancer Care Series, Gynecologic Cancer, New York, Springer, 2006, 125.
11. Gadducci A., Cosio S., Romanini A., Genazzani A.R.: "The management of patients with uterine sarcoma: a debated clinical challenge". Crit. Rev. Oncol. Hematol., 2008, 65, 129.
12. Zelmanowicz A., Hildesheim A., Sherman M.E., Sturgeon S.R., Kurman R.J., Barrett R.J. et al.: "Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors". Gynecol. Oncol., 1998, 69, 253. (Pubitemid 28289969)
13. McCluggage W.G.: "Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas". Int. J. Gynecol. Cancer, 2002, 12, 687.
14. Leibsohn S., d'Ablaing G., Mishell D.R. Jr., Schlaerth J.B.: "Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas". Am. J. Obstet. Gynecol., 1990, 162, 968.
15. Bell S.W., Kempson R.L., Hendrickson M.R.: "Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases". Am. J. Surg. Pathol., 1994, 18, 535.
16. Kempson R.L., Hendrickson M.R.: "Smooth muscle, endometrial stromal, and mixed Müllerian tumors of the uterus". Mod. Pathol., 2000, 13, 328.
17. Diesing D., Cordes T., Finas D., Löning M., Mayer K., Diedrich K. et al.: "Endometrial stromal sarcomas-a retrospective analysis of 11 patients". Anticancer Res., 2006, 26, 655. (Pubitemid 43206031)
18. Gadducci A., Sartori E., Landoni F., Zola P., Maggino T., Urgesi A. et al.: "Endometrial stromal sarcoma: analysis of treatment failures and survival". Gynecol Oncol., 1996, 63, 247. (Pubitemid 26398607)
19. Olá K.S., Gee H., Blunt S., Dunn J.A., Kelly K., Chan K.K.: "Retrospective analysis of 318 cases of uterine sarcoma". Eur. J. Cancer, 1991, 27, 1095.
20. Li N., Wu L.Y., Zhang H.T., An J.S., Li X.G., Ma S.K.: "Treatment options in Stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases". Gynecol. Oncol., 2008, 108, 306. (Pubitemid 351174299)
21. Amant F., Vergote I., Moerman P.: "The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned". Gynecol. Oncol., 2004, 95, 412. (Pubitemid 39445884)
22. Berchuck A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., Lewis J.L. Jr.: "Treatment of endometrial stromal tumors". Gynecol. Oncol., 1990, 36, 60.
23. Ali S., Wells M.: "Mixed Mullerian tumors of the uterine corpus: a review". Int. J. Gynecol. Cancer, 1993, 3, 1. (Pubitemid 23207590)
24. Iwasa Y., Haga H., Konishi I., Kobashi Y., Higuchi K., Katsuyama E. et al.: "Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients". Cancer, 1998, 82, 512. (Pubitemid 28112990)
25. Sreenan J.J., Hart W.R.: "Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis". Am. J. Surg. Pathol., 1995, 19, 666.
26. Yamada S.D., Burger R.A., Brewster W.R., Anton D., Kohler M.F., Monk B.J.: "Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus". Cancer, 2000, 88, 2782. (Pubitemid 30417939)
27. Major F.J., Blessing J.A., Silverberg S.G., Morrow C.P., Creasman W.T., Currie J.L. et al.: "Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study". Cancer, 1993, 71, 1702.
28. Temkin S.M., Hellmann M., Lee Y.C., Abulafia O.: "Early-stage carcinosarcoma of the uterus: the significance of lymph node count". Int. J. Gynecol. Cancer, 2007, 17, 215. (Pubitemid 46213993)
29. Akahira J., Tokunaga H., Toyoshima M., Takano T., Nagase S., Yoshinaga K. et al.: "Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma". Oncology, 2006, 71, 333.
30. Chauveinc L., Deniaud E., Plancher C., Sastre X., Amsani F., de la Rochefordiere A. et al.: "Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments". Gynecol. Oncol., 1999, 72, 232. (Pubitemid 29093780)
31. Vaidya A.P., Horowitz N.S., Oliva E., Halpern E.F., Duska L.R.: "Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma". Gynecol. Oncol., 2006, 103, 684. (Pubitemid 44602187)
32. El Husseiny G., Al Bareedy N., Mourad W.A., Mohamed G., Shoukri M., Subhi J. et al: "Prognostic factors and treatment modalities in uterine sarcoma". Am. J. Clin. Oncol., 2002, 25, 256. (Pubitemid 34602546)
33. Akhan S.E., Yavuz E., Tecer A., Iyibozkurt C.A., Topuz S., Tuzlali S. et al.: "The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study". Gynecol. Oncol., 2005, 99, 36. (Pubitemid 41354580)
34. Leitao M.M., Soslow R.A., Nonaka D., Olshen A.B., Aghajanian C., Sabbatini P. et al.: "Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma". Cancer, 2004, 101, 1455. (Pubitemid 39180402)
35. Gadducci A., Landoni F., Sartori E., Zola P., Maggino T., Lissoni A. et al.: "Uterine leiomyosarcoma: analysis of treatment failures and survival". Gynecol Oncol., 1996, 62, 25. (Pubitemid 26398607)
36. De Fusco P.A., Gaffey T.A., Malkasian G.D. Jr., Long H.J., Cha S.S.: "Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980". Gynecol. Oncol., 1989, 35, 8.
37. rd, Seidman J.D., Krivak T.C., Chauhan S., Carlson J.W., Rose G.S. et al.: "Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus". Gynecol. Oncol., 2003, 91, 3.
38. rd, Alvarez R.D., Partridge E.E. et al.: "Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series". J. Reprod. Med., 2004, 49, 71.
39. Raspollini M.R., Susini T., Amunni G., Paglierani M., Taddei A., Marchionni M. et al.: "COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?". Gynecol. Oncol., 2005, 96, 159. (Pubitemid 39612431)
40. Menczer J., Kravtsov V., Levy T., Berger E., Glezerman M., Avinoach I.: "Expression of c-kit in uterine carcinosarcoma". Gynecol. Oncol., 2005, 96, 210.
41. Sawada M., Tsuda H., Kimura M., Okamoto S., Kita T., Kasamatsu T. et al.: "Different expression patterns of KIT, EGFR, and HER-2 (c-erbB-2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma". Cancer Sci, 2003, 94, 986. (Pubitemid 37508982)
42. Raspollini M.R., Susini T., Amunni G., Paglierani M., Castiglione F., Garbini F. et al.: "Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment?". Int. J. Gynecol. Cancer, 2006, 16, 416.
43. Ansink A.C., Cross P.A., Scorer P., de Barros Lopes A., Monaghan J.M.: "The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study". J. Clin. Pathol., 1997, 50, 328. (Pubitemid 27208253)
44. Cimbaluk D., Rotmensch J., Scudiere J., Gown A., Bitterman P.: "Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets". Gynecol. Oncol., 2007, 105, 138. (Pubitemid 46441450)
45. Taylor N.P., Zighelboim I., Huettner P.C., Powell M.A., Gibb R.K., Rader J.S. et al.: "DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis". Mod. Pathol., 2006, 19, 1333. (Pubitemid 44423080)
46. Abargel A., Avinoach I., Kravtsov V., Boaz M., Glezerman M., Menczer J.: "Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma". Int. J. Gynecol. Cancer, 2004, 14, 354. (Pubitemid 38533909)
47. Szukala S.A., Marks J.R., Burchette J.L., Elbendary A.A., Krigman H.R.: "Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: an immunohistochemical study of 19 cases". Int. J. Gynecol. Cancer, 1999, 9, 131.
48. Mayall F., Rutty K., Campbell F., Goddard H.: "p53 immunostaining suggests that uterine carcinosarcomas are monoclonal". Histopathology, 1994, 24, 211. (Pubitemid 24192294)
49. Nicòtina P.A., Ferlazzo G., Vincelli A.M.: "Proliferation indices and p53-immunocytochemistry in uterine mixed mullerian tumors". Histol. Histopathol., 1997, 12, 967. (Pubitemid 27410453)
50. Amant F., de la Rey M., Dorfling C.M., van der Walt L., Dreyer G., Dreyer L. et al.: "PTEN mutations in uterine sarcomas". Gynecol. Oncol., 2002, 85, 165.
51. Bodner K., Bodner-Adler B., Kimberger O., Czerwenka K., Leodolter S., Mayerhofer K.: "Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters". Anticancer Res., 2003, 23, 729. (Pubitemid 36358480)
52. Raspollini M.R., Amunni G., Villanucci A., Boddi V., Simoni A., Taddei A. et al.: "Estrogen and progesterone receptors expression in uterine malignant smooth muscle tumors: correlation with clinical outcome". J. Chemother., 2003, 15, 596. (Pubitemid 38241410)
53. Kelley T.W., Borden E.C., Goldblum J.R.: "Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study". Appl. Immunohistochem Mol. Morphol., 2004, 12, 338.
54. Esposito N.N., Hunt J.L., Bakker A., Jones M.W.: "Analysis of allelic loss as an adjuvant tool in evaluation of malignancy in uterine smooth muscle tumors". Am. J. Surg. Pathol., 2006, 30, 97. (Pubitemid 43740215)
55. Comunoǧlu N.U., Durak H., Comunoglu C., Ekici A.I., Ozkan F., Akyildiz E.U. et al.: "Expression of cyclooxygenase-2, c-kit, progesterone and estrogen receptors in uterine smooth muscle tumors: differential diagnosis". APMIS, 2007, 115, 726. (Pubitemid 46854992)
56. Raspollini M.R., Pinzani P., Simi L., Amunni G., Villanucci A., Paglierani M. et al.: "Uterine leiomyosarcomas express KIT protein but lack mutation(s) in exon 9 of c-KIT". Gynecol. Oncol., 2005, 98, 334. (Pubitemid 41019129)
57. Raspollini M.R., Paglierani M., Taddei G.L., Villanucci A., Amunni G., Taddei A.: "The protooncogene c-KIT is expressed in leiomyosarcomas of the uterus". Gynecol. Oncol., 2004, 93, 718. (Pubitemid 38766063)
58. Wang L., Felix J.C., Lee J.L., Tan P.Y., Tourgeman D.E., O'Meara A.T. et al.: "The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus". Gynecol. Oncol., 2003, 90, 402. (Pubitemid 36952035)
59. Raspollini M.R., Amunni G., Villanucci A., Pinzani P., Simi L., Paglierani M. et al.: "c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment". Clin. Cancer Res., 2004, 10, 3500. (Pubitemid 38685458)
60. Raspollini M.R., Villanucci A., Amunni G., Paglierani M., Taddei A., Taddei C.L.: "C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus". J. Chemother., 2003, 15, 81. (Pubitemid 36349897)
61. Rushing R.S., Shajahan S., Chendil D., Wilder J.L., Pulliam J., Lee E.Y. et al.: "Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT". Gynecol. Oncol., 2003, 91, 9. (Pubitemid 37188589)
62. Serrano C., Mackintosh C., Herrero D., Martins A.S., de Alava E., Hernández T. et al.: "Imatinib is not a potential alternative treatment for uterine leiomyosarcoma". Clin. Cancer Res., 2005, 11, 4977-9; author reply 4979-4980 (Pubitemid 41557220)
63. Shpitz B., Tiomkin V., Bomstein Y., Gralkin M., Buklan H., Bernheim J. et al.: "Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas". Eur. J. Surg. Oncol., 2001, 27, 203. (Pubitemid 32621736)
64. Anderson S.E., Nonaka D., Chuai S., Olshen A.B., Chi D., Sabbatini P. et al.: "p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas". Int. J. Gynecol. Cancer, 2006, 16, 849.
65. Sprogoe-Jakobsen S., Holund B.: "Immunohistochemistry (Ki-67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus)". APMIS, 1996, 104, 705. (Pubitemid 26400402)
66. Hall K.L., Teneriello M.G., Taylor R.R., Lemon S., Ebina M., Linnoila R.I. et al.: "Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas". Gynecol. Oncol., 1997, 65, 330. (Pubitemid 27216950)
67. Jeffers M.D., Farquharson M.A., Richmond J.A., McNicol A.M.: "p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus". J. Pathol., 1995, 177, 65.
68. de Vos S., Wilczynski S.P., Fleischhacker M., Koeffler P.: "p53 alterations in uterine leiomyosarcomas versus leiomyomas". Gynecol. Oncol., 1994, 54, 205. (Pubitemid 2117715)
69. Amant F., Vloeberghs V., Woestenborghs H., Debiec-Rychter M., Verbist L., Moerman P. et al.: "ERBB-2 gene overexpression and amplification in uterine sarcomas". Gynecol. Oncol., 2004, 95, 583. (Pubitemid 39592525)
70. Kurihara S., Oda Y., Ohishi Y., Iwasa A., Takahira T., Kaneki E. et al.: "Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases". Am. J. Surg. Pathol., 2008, 32, 1228.
71. Kim L., Choi S.J., Park I.S., Han J.Y., Kim J.M., Chu Y.C. et al.: "Endometrial stromal sarcoma of the small bowel". Ann. Diagn. Pathol., 2008, 12, 128.
72. Balleine R.L., Earls P.J., Webster L.R., Mote P.A., deFazio A., Harnett P.R. et al.: "Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma". Int. J. Gynecol. Pathol., 2004, 23, 138.
73. Al-Salam S., El-Terifi H., Ghazal-Aswad S.: "Low-grade endometrial stromal sarcoma with sex cord-like differentiation metastatic to the thoracic spines". APMIS, 2006, 114, 651. (Pubitemid 44337345)
74. Moinfar F., Regitnig P., Tabrizi A.D., Denk H., Tavassoli F.A.: "Expression of androgen receptors in benign and malignant endometrial stromal neoplasms". Virchows Arch., 2004, 444, 410. (Pubitemid 38703756)
75. Chu M.C., Mor G., Lim C., Zheng W., Parkash V., Schwartz P.E.: "Low-grade endometrial stromal sarcoma: hormonal aspects". Gynecol. Oncol., 2003, 90, 170. (Pubitemid 37338093)
76. Reich O., Regauer S., Urdl W., Lahousen M., Winter R.: "Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas". Br. J. Cancer, 2000, 82, 1030. (Pubitemid 30128855)
77. Navarro D., Cabrera J.J., León L., Chirino R., Fernández L., López A. et al.: "Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness". J. Steroid. Biochem. Mol. Biol., 1992, 41, 589.
78. Sabini G., Chumas J.C., Mann W.J.: "Steroid hormone receptors in endometrial stromal sarcomas. A biochemical and immunohistochemical study". Am. J. Clin. Pathol., 1992, 97, 381.
79. Kir G., Cetiner H., Karateke A., Gurbuz A., Bulbul D.: "Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas". Int. J. Gynecol. Cancer, 2005, 15, 337. (Pubitemid 40396975)
80. Zhu X.Q., Shi Y.F., Cheng X.D., Zhao C.L., Wu Y.Z.: " Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma". Gynecol. Oncol., 2004, 92, 71.
81. Popiolek D., Yee H., Levine P., Vamvakas E., Demopoulos R.I.: "MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus". Gynecol. Oncol., 2003, 90, 353. (Pubitemid 36952026)
82. Nordal R.R., Kristensen G.B., Stenwig A.E., Tropé C.G., Nesland J.M.: "Immunohistochemical analysis of p53 protein in uterine sarcomas". Gynecol. Oncol., 1998, 70, 45.
83. Klein W.M., Kurman R.J.: "Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary". Int. J. Gynecol. Pathol., 2003, 22, 181.
84. Moinfar F., Gogg-Kamerer M., Sommersacher A., Regitnig P., Man Y.G., Zatloukal K. et al.: "Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1): potential basis for a new therapeutic approach". Am. J. Surg. Pathol., 2005, 29, 485. (Pubitemid 40411180)
85. Caudell J.J., Deavers M.T., Slomovitz B.M., Lu K.H., Broaddus R.R., Gershenson D.M. et al.: "Imatinib mesylate (gleevec)-targeted kinases are expressed in uterine sarcomas". Appl. Immunohistochem. Mol. Morphol., 2005, 13, 167.
86. nd, Garrett-Mayer E., Bristow R.E., Gostout B.S.: "Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma". Gynecol. Oncol., 2007, 106, 82.
87. Dinh T.A., Oliva E.A., Fuller A.F. Jr, Lee H., Goodman A.: "The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital". Gynecol. Oncol., 2004, 92, 648.
88. Vrzic-Petronijevic S., Likic-Ladjevic I., Petronijevic M., Argirovic R., Ladjevic N.: "Diagnosis and surgical therapy of uterine sarcoma". Acta Chir. Iugosl., 2006, 53, 67.
89. Benoit L., Arnould L., Cheynel N., Goui S., Collin F., Fraisse J. et al.: "The role of surgery and treatment trends in uterine sarcoma". Eur. J. Surg. Oncol., 2005, 31, 434. (Pubitemid 40521313)
90. Kanjeekal S., Chambers A., Fung M.F., Verma S.: "Systemic therapy for advanced uterine sarcoma: a systematic review of the literature". Gynecol. Oncol., 2005, 97, 624. (Pubitemid 40614914)
91. Kokawa K., Nishiyama K., Ikeuchi M., Ihara Y., Akamatsu N., Enomoto T. et al.: "Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003)". Int. J. Gynecol. Cancer, 2006, 16, 1358. (Pubitemid 43886769)
92. Nemani D., Mitra N., Guo M., Lin L.: "Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: A SEER analysis". Gynecol. Oncol., 2008; [Epub ahead of print].
93. nd, Metzinger D.S., DiMarco C.S., Cha S.S., Sloan J.A., Keeney G.L. et al.: "Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy". Gynecol. Oncol., 2003, 89, 460.
94. Gard G.B., Mulvany N.J., Quinn M.A.: "Management of uterine leiomyosarcoma in Australia". Aust. N.Z.J. Obstet. Gynaecol., 1999, 39, 93.
95. Weitmann H.D., Kucera H., Knocke T.H., Pötter R.: "Surgery and adjuvant radiation therapy of endometrial stromal sarcoma". Wien Klin Wochenschr., 2002, 114, 44. (Pubitemid 34112657)
96. Weitmann H.D., Knocke T.H., Kucera H., Pötter R.: "Radiation therapy in the treatment of endometrial stromal sarcoma". Int. J. Radiat. Oncol. Biol. Phys., 2001, 49, 739. (Pubitemid 32112199)
97. Riopel J., Plante M., Renaud M.C., Roy M., Têtu B.: "Lymph node metastases in low-grade endometrial stromal sarcoma". Gynecol. Oncol., 2005, 96, 402. (Pubitemid 40127141)
98. Reich O., Winter R., Regauer S.: "Should lymphadenectomy be performed in patients with endometrial stromal sarcoma?". Gynecol. Oncol., 2005, 97, 982.
99. Reich O., Regauer S.: "Survey of adjuvant hormone therapy in patients after endometrial stromal sarcoma". Eur. J. Gynaecol. Oncol., 2006, 27, 150.
100. Reed N.S.: "The management of uterine sarcomas". Clin. Oncol. (R Coll Radiol.), 2008, 20, 470.
101. Hornback N.B., Omura G., Major F.J.: "Observations on the use of adjuvant radiation therapy in patients with Stage I and II uterine sarcoma". Int. J. Radiat. Oncol. Biol. Phys., 1986, 12, 2127. (Pubitemid 17215527)
102. Reed N.S., Mangioni C., Malmström H., Scarfone G., Poveda A., Pecorelli S. et al.: "Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas Stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)". Eur. J. Cancer, 2008, 44, 808.
103. Dusenbery K.E., Polish R.A., Argenta P.A., Judson P.L.: "On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus". Am. J. Clin. Oncol., 2005, 28, 295.
104. Callister M., Ramondetta L.M., Jhingran A., Burke T.W., Eifel P.J.: "Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome". Int. J. Radiat. Oncol. Biol. Phys., 2004, 58, 786. (Pubitemid 38221136)
105. Wolfson A.H., Brady M.F., Rocereto T., Mannel R.S., Lee Y.C., Futoran R.J. et al.: "A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in Stage I-IV carcinosarcoma (CS) of the uterus". Gynecol. Oncol., 2007, 107, 177. (Pubitemid 47575740)
106. Brooks S.E., Zhan M., Cote T., Baquet C.R.: "Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999". Gynecol. Oncol., 2004, 93, 204.
107. Clayton Smith D., Kenneth Macdonald O., Gaffney D.K.: "The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma". Radiother. Oncol., 2008, 88, 227.
108. Wright J.D., Seshan V.E., Shah M., Schiff P.B., Burke W.M., Cohen C.J. et al.: "The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma". Am. J. Obstet. Gynecol., 2008 [Epub ahead of print].
109. Berceanu S., Pǎtraşcu A., Berceanu C., Tica A.A., Bǎdulescu A.: "Endometrial stromal sarcoma: clinico-pathological report of four cases and review of the literature". Rom. J. Morphol. Embryol., 2008, 49, 251.
110. Ihnen M., Mahner S., Jänicke F., Schwarz J.: "Current treatment options in uterine endometrial stromal sarcoma: report of a case and review of the literature". Int. J. Gynecol. Cancer, 2007, 17, 957. (Pubitemid 47414812)
111. Ishiko O., Wakasa K., Honda K., Nakajima S., Ogita S.: "Excellent results of postoperative radiotherapy for endometrial stromal sarcoma of low-grade malignancy". Gynecol. Obstet. Invest., 2000, 49, 214. (Pubitemid 30195657)
112. Livi L., Andreopoulou E., Shah N., Paiar F., Blake P., Judson I. et al.: "Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998". Clin. Oncol., 2004, 16, 261. (Pubitemid 38696967)
113. Reich O., Regauer S.: "Hormonal therapy of endometrial stromal sarcoma". Curr. Opin. Oncol., 2007, 19, 347. (Pubitemid 46883524)
114. Omura G.A., Major F.J., Blessing J.A., Sedlacek T.V., Thigpen J.T., Creasman W.T. et al.: "A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas". Cancer, 1983, 52, 626.
115. Muss H.B., Bundy B., DiSaia P.J., Homesley H.D., Fowler W.C. Jr., Creasman W. et al.: "Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group)". Cancer, 1985, 55, 1648. (Pubitemid 15103908)
116. rd, Rivkin S.E., Smith M.R., Tesh D.E.: "Cisplatin and adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors". Gynecol. Oncol., 1989, 34, 323.
117. Sartori E., Bazzurini L., Gadducci A., Landoni F., Lissoni A., Maggino T et al.: "Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study". Gynecol. Oncol., 1997, 67, 70. (Pubitemid 27433331)
118. Kohorn E.I., Schwartz P.E., Chambers J.T., Peschel R.E., Kapp D.S., Merino M.: "Adjuvant therapy in mixed mullerian tumors of the uterus". Gynecol. Oncol., 1986, 23, 212.
119. Jansen R.L., van der Burg M.E., Verweij J., Stoter G.: "Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract". Eur. J. Cancer Clin. Oncol., 1987, 23, 1131. (Pubitemid 17112474)
120. Leyvraz S., Bacchi M., Cerny T., Lissoni A., Sessa C., Bressoud A. et al.: "Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)". Ann. Oncol., 1998, 9, 877.
121. Sutton G., Blessing J.A., Malfetano J.H.: "Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study". Gynecol. Oncol., 1996, 62, 226. (Pubitemid 26274804)
122. Sutton G.P., Soper J.T., Blessing J.A., Hatch K.D., Barnhill D.R.: "Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease". Am. J. Obstet. Gynecol., 1992, 167, 489.
123. Sutton G.P., Blessing J.A., Rosenshein N., Photopulos G., DiSaia P.J.: "Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study)". Am. J. Obstet. Gynecol., 1989, 161, 309. (Pubitemid 19212192)
124. Sutton G., Brunetto V.L., Kilgore L., Soper J.T., McGehee R., Olt G. et al.: "A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study". Gynecol. Oncol., 2000, 79, 147. (Pubitemid 30822909)
125. Homesley H.D., Filiaci V., Markman M., Bitterman P., Eaton L., Kilgore L.C. et al.: "Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study". J. Clin. Oncol., 2007, 25, 526. (Pubitemid 350002959)
126. Thigpen J.T., Blessing J.A., Beecham J., Homesley H., Yordan E.: "Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study". J. Clin. Oncol., 1991, 9, 1962.
127. Curtin J.P., Blessing J.A., Soper J.T., DeGeest K.: "Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study". Gynecol. Oncol., 2001, 83, 268.
128. Toyoshima M., Akahira J., Matsunaga G., Niikura H., Ito K., Yaegashi N. et al.: "Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus". Gynecol. Oncol., 2004, 94, 774. (Pubitemid 39194474)
129. Menczer J., Levy T., Piura B., Chetrit A., Altaras M., Meirovitz M. et al.: "A comparison between different postoperative treat- ment modalities of uterine carcinosarcoma". Gynecol. Oncol., 2005, 97, 166. (Pubitemid 40403689)
130. Favette J., Coquard I.R., Alberti L. et al.: "ET-743: a novel agent with activity in soft tissue sarcomas". Current Opin. Oncol., 2005, 98, 99.
131. Anderson S., Aghajanian C.: "Temozolomide in uterine leiomyosarcomas". Gynecol. Oncol., 2005, 98, 99.
132. Sutton G., Blessing J., Hanjani P., Kramer P., Gynecologic Oncology Group: "Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study". Gynecol. Oncol., 2005, 96, 749. (Pubitemid 40255496)
133. rd, Rose P.G., Gynecologic Oncology Group (GOG) Study: "Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study". Gynecol. Oncol., 2004, 92, 644. (Pubitemid 38183157)
134. Hensley M.L., Maki R., Venkatraman E., Geller G., Lovegren M., Aghajanian C. et al.: "Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial". J. Clin. Oncol., 2002, 20, 2824. (Pubitemid 34651511)